Patrick Salmon

After qualifying as a physician Patrick Salmon spent several years in clinical medicine later entering the area of clinical research.

While working for Contract Research Organisation in Ireland and the UK, Patrick organised and ran phase 1, 2, and 3 studies. After a short period working with a pharmaceutical company, he joined the Irish regulatory agency in 1994 and has worked there since, assessing medical aspects of all types of applications.

His areas of involvement include clinical trial assessment; mutual recognition and decentralised applications; and centralised applications.

In 2000, Patrick became a member of the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA). Later in 2004, he became an Irish delegate on the Committee for Orphan Medicinal Products (COMP) also at the EMA.

Additional interests include Product Information and he is Chair of the CHMP ad hoc group on the SmPC (Summary of Product Characteristics) and the CMD(h) (Co-ordination group for Mutual Recognition and Decentralised Procedures (human)) subgroup on harmonisation of the SmPC.

www.imb.ie

 
 
La voz de los pacientes de enfermedades raras en EuropaEURORDIS La voz internacional de las personas que tienen enfermedades rarasRare Disease International Reuniendo a pacientes, familiares y expertos para compartir experiencias en un foro moderado en distintos idiomas. RareConnect El Programa Rare Barometer es una iniciativa de EURORDIS que realiza encuestas para transformar las experiencias de los pacientes con enfermedades raras en cifras que puedan compartirse con los responsables políticos.Rare Barometer Una campaña internacional de sensibilización que se celebra todos los años el último día de febrero, El Día de las Enfermedades Raras es una iniciativa de EURORDISRare Disease Day Únete al mayor grupo de partes interesadas en toda Europa, en la Conferencia Europea sobre Enfermedades Raras y Medicamentos Huérfanos que se celebra cada dos años. ECRD es una iniciativa de EURORDISEuropean Conference on Rare Diseases